King Street Capital Management’s Surgery Partners SGRY Stock Holding History

King Street Capital Management’s Portfolio SGRY Stock Details SGRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$102M	Sell	6,058,141 -4,171,589	-41%	-$58.6M	53.66%	1
2026 Q1	$122M	Hold	10,229,730	–	–	37.17%	1
2025 Q4	$158M	Buy	10,229,730 +889,800	+10%	+$16.4M	21.82%	1
2025 Q3	$202M	Buy	9,339,930 +3,114,930	+50%	+$69.5M	8.65%	3
2025 Q2	$138M	Buy	6,225,000 +1,225,000	+25%	+$27.2M	13.18%	3
2025 Q1	$119M	Buy	5,000,000 +2,200,000	+79%	+$52.1M	13.78%	3
2024 Q4	$59.3M	Buy	2,800,000 +1,350,000	+93%	+$35.4M	8.99%	6
2024 Q3	$46.7M	Buy	+1,450,000	New	+$42.8M	32.28%	1
2021 Q1	–	Sell	-1,000,000	Closed	-$29M	–	115
2020 Q4	$29M	Sell	1,000,000 -878,733	-47%	-$21.9M	4.44%	10
2020 Q3	$41.1M	Sell	1,878,733 -29,669	-2%	-$527K	4.43%	9
2020 Q2	$22.1M	Hold	1,908,402	–	–	1.95%	15
2020 Q1	$12.5M	Buy	1,908,402 +908,402	+91%	+$12.9M	1.39%	9
2019 Q4	$15.7M	Buy	1,000,000 +879,526	+730%	+$9.98M	0.77%	10
2019 Q3	$890K	Buy	+120,474	New	+$863K	0.07%	13

Other funds holding SGRY

BCI

Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return

Jupiter Topco New York $245B AUM

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

King Street Capital Management's SGRY Position: Q2 2026 in Review

King Street Capital Management reduced its Surgery Partners (SGRY) stake by 41% in Q2 2026, selling an estimated $58.6M and leaving 6,058,141 shares worth $102M. The position accounts for 53.66% of the portfolio, ranked #1.

King Street Capital Management first reported a position in SGRY in Q3 2019 and has held it in 14 quarters since. The position peaked at $202M in Q3 2025. 187 funds tracked by Wall St. Rank hold SGRY as of Q2 2026.

King Street Capital Management held 6,058,141 shares of Surgery Partners worth $102M as of Q2 2026.
King Street Capital Management sold 4,171,589 Surgery Partners shares in Q2 2026, an estimated $58.6M.
Surgery Partners made up 53.66% of King Street Capital Management's portfolio in Q2 2026, its #1 holding.
King Street Capital Management first reported a position in Surgery Partners in Q3 2019 and has held it in 14 quarters since.
King Street Capital Management's Surgery Partners position peaked at $202M in Q3 2025.
187 funds tracked by Wall St. Rank held Surgery Partners as of Q2 2026.

Based on King Street Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.